Erythropoietin-producing hepatocellular (Eph) receptor type A8 (EphA8) expression was associated with poor prognosis of patients with gastric cancer, and its knockdown decreased the expression of ADAM10, indicating that EphA8 is an upstream regulator of ADAM1052. This evidence concerns the gene EPHA8 and gastric cancer.